论文部分内容阅读
目的观察益气解毒祛瘀方联合内分泌疗法治疗中期前列腺癌的临床效果。方法选取医院的中期前列腺癌患者60例为研究对象,随机分为对照组和观察组,每组30例。对照组给予西医内分泌疗法治疗,观察组在对照组治疗基础上采用益气解毒祛瘀方进行治疗。比较2组患者治疗效果,观察2组治疗前后血清前列腺特异抗原(PSA)、游离前列腺特异性抗原(f-PSA)、血红蛋白(Hb)数值变化。结果观察组总有效率为96.67%,高于对照组的73.34%(P<0.05)。治疗后,观察组PSA、f-PSA明显下降,Hb明显升高,效果优于对照组,差异有统计学意义(P<0.05)。结论采用益气解毒祛瘀方联合内分泌治疗中期前列腺癌的临床效果较佳,值得临床推广应用。
Objective To observe the clinical efficacy of Yiqi Jiedu Quyu Decoction combined with endocrine therapy in the treatment of mid-term prostate cancer. Methods Sixty patients with mid-stage prostate cancer were selected as study subjects and randomly divided into control group and observation group with 30 cases in each group. The control group was treated with western medicine endocrine therapy. The observation group was treated with Yiqi Jiedu Quyu Decoction on the basis of the control group. The therapeutic effects were compared between the two groups. The changes of serum PSA, f-PSA and hemoglobin before and after treatment were observed. Results The total effective rate in the observation group was 96.67%, which was higher than that in the control group (73.34%, P <0.05). After treatment, the levels of PSA and f-PSA in the observation group decreased significantly, while the levels of Hb in the observation group were significantly higher than those in the control group. The difference was statistically significant (P <0.05). Conclusions The clinical effect of using Yiqi Jiedu Quyu Decoction in combination with endocrine in the treatment of mid-term prostate cancer is better and worthy of clinical application.